SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-156044
Filing Date
2024-06-06
Accepted
2024-06-06 16:05:55
Documents
15
Period of Report
2024-06-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d675020d8k.htm   iXBRL 8-K 41910
2 EX-3.1 d675020dex31.htm EX-3.1 7018
3 EX-3.2 d675020dex32.htm EX-3.2 102163
  Complete submission text file 0001193125-24-156044.txt   317059

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vigl-20240605.xsd EX-101.SCH 2859
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vigl-20240605_lab.xml EX-101.LAB 20245
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vigl-20240605_pre.xml EX-101.PRE 12608
18 EXTRACTED XBRL INSTANCE DOCUMENT d675020d8k_htm.xml XML 4125
Mailing Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472
Business Address 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41200 | Film No.: 241025035
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)